Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial.

Skjerven HO, Rehbinder EM, Vettukattil R, LeBlanc M, Granum B, Haugen G, Hedlin G, Landrø L, Marsland BJ, Rudi K, Sjøborg KD, Söderhäll C, Staff AC, Carlsen KH, Asarnoj A, Bains KES, Carlsen OCL, Endre KMA, Granlund PA, Hermansen JU, Gudmundsdóttir HK, Hilde K, Håland G, Kreyberg I, Olsen IC, Mägi CO, Nordhagen LS, Saunders CM, Skrindo I, Tedner SG, Værnesbranden MR, Wiik J, Jonassen CM, Nordlund B, Carlsen KCL.

Lancet. 2020 Mar 21;395(10228):951-961. doi: 10.1016/S0140-6736(19)32983-6. Epub 2020 Feb 19. Erratum in: Lancet. 2020 Mar 21;395(10228):e53.

PMID:
32087121
2.

Food and nutrient intake and adherence to dietary recommendations during pregnancy: a Nordic mother-child population-based cohort.

Saunders CM, Rehbinder EM, Carlsen KCL, Gudbrandsgard M, Carlsen KH, Haugen G, Hedlin G, Jonassen CM, Sjøborg KD, Landrø L, Nordlund B, Rudi K, O Skjerven H, Söderhäll C, Staff AC, Vettukattil R, Carlsen MH.

Food Nutr Res. 2019 Dec 20;63. doi: 10.29219/fnr.v63.3676. eCollection 2019.

3.

Snus in pregnancy and infant birth size: a mother-child birth cohort study.

Kreyberg I, Hilde K, Bains KES, Carlsen KH, Granum B, Haugen G, Hedlin G, Jonassen CM, Nordhagen LS, Nordlund B, Rueegg CS, Sjøborg KD, Skjerven HO, Staff AC, Vettukattil R, Lødrup Carlsen KC; PreventADALL Study Group.

ERJ Open Res. 2019 Dec 2;5(4). pii: 00255-2019. doi: 10.1183/23120541.00255-2019. eCollection 2019 Oct.

4.

Predicting Skin Barrier Dysfunction and Atopic Dermatitis in Early Infancy.

Rehbinder EM, Advocaat Endre KM, Lødrup Carlsen KC, Asarnoj A, Stensby Bains KE, Berents TL, Carlsen KH, Gudmundsdóttir HK, Haugen G, Hedlin G, Kreyberg I, Nordhagen LS, Nordlund B, Saunders CM, Sandvik L, Skjerven HO, Söderhäll C, Staff AC, Vettukattil R, Værnesbranden MR, Landrø L; study group, Carlsen MH, Lødrup Carlsen OC, Granlund PA, Granum B, Götberg S, Hilde K, Jonassen CM, Nygaard UC, Rudi K, Skrindo I, Sjøborg K, Tedner SG, Wiik J, Winger AJ.

J Allergy Clin Immunol Pract. 2020 Feb;8(2):664-673.e5. doi: 10.1016/j.jaip.2019.09.014. Epub 2019 Sep 27.

PMID:
31568931
5.

Maternal and paternal atopic dermatitis and risk of atopic dermatitis during early infancy in girls and boys.

Endre KMA, Rehbinder EM, Carlsen KL, Carlsen KH, Gjersvik P, Hedlin G, Jonassen CM, LeBlanc M, Nordlund B, Skjerven HO, Staff AC, Söderhäll C, Vettukattil R, Landrø L; study group.

J Allergy Clin Immunol Pract. 2020 Jan;8(1):416-418.e2. doi: 10.1016/j.jaip.2019.06.039. Epub 2019 Jul 15. No abstract available.

PMID:
31319220
6.

Dry skin and skin barrier in early infancy.

Rehbinder EM, Winger AJ, Landrø L, Asarnoj A, Berents TL, Carlsen KH, Hedlin G, Jonassen CM, Nordlund B, Sandvik L, Skjerven HO, Söderhäll C, Vettukattil R, Carlsen KCL; PreventADALL study group.

Br J Dermatol. 2019 Jul;181(1):218-219. doi: 10.1111/bjd.17626. Epub 2019 Apr 12. No abstract available.

PMID:
30637724
7.

Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment.

Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF.

Br J Cancer. 2018 Oct;119(9):1144-1154. doi: 10.1038/s41416-018-0211-x. Epub 2018 Nov 7.

8.

Preventing Atopic Dermatitis and ALLergies in Children-the PreventADALL study.

Lødrup Carlsen KC, Rehbinder EM, Skjerven HO, Carlsen MH, Fatnes TA, Fugelli P, Granum B, Haugen G, Hedlin G, Jonassen CM, Landrø L, Lunde J, Marsland BJ, Nordlund B, Rudi K, Sjøborg K, Söderhäll C, Staff AC, Vettukattil R, Carlsen KH; study group.

Allergy. 2018 Oct;73(10):2063-2070. doi: 10.1111/all.13468. Epub 2018 Jun 19. No abstract available.

PMID:
29710408
9.

Early metabolite changes after melatonin treatment in neonatal rats with hypoxic-ischemic brain injury studied by in-vivo1H MR spectroscopy.

Berger HR, Nyman AKG, Morken TS, Vettukattil R, Brubakk AM, Widerøe M.

PLoS One. 2017 Sep 21;12(9):e0185202. doi: 10.1371/journal.pone.0185202. eCollection 2017.

10.

Tissue Microstructure Is Linked to MRI Parameters and Metabolite Levels in Prostate Cancer.

Selnæs KM, Vettukattil R, Bertilsson H, Wright AJ, Heerschap A, Angelsen A, Tessem MB, Bathen TF.

Front Oncol. 2016 Jun 14;6:146. doi: 10.3389/fonc.2016.00146. eCollection 2016.

11.

Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.

Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I.

Lipids Health Dis. 2016 Mar 12;15:56. doi: 10.1186/s12944-016-0225-4.

12.

Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model.

Kim E, Tunset HM, Cebulla J, Vettukattil R, Helgesen H, Feuerherm AJ, Engebråten O, Mælandsmo GM, Johansen B, Moestue SA.

BMC Cancer. 2016 Mar 7;16:191. doi: 10.1186/s12885-016-2225-1.

13.

Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies.

Haukaas TH, Moestue SA, Vettukattil R, Sitter B, Lamichhane S, Segura R, Giskeødegård GF, Bathen TF.

Front Oncol. 2016 Jan 28;6:17. doi: 10.3389/fonc.2016.00017. eCollection 2016.

14.

No improvement of neuronal metabolism in the reperfusion phase with melatonin treatment after hypoxic-ischemic brain injury in the neonatal rat.

Berger HR, Morken TS, Vettukattil R, Brubakk AM, Sonnewald U, Widerøe M.

J Neurochem. 2016 Jan;136(2):339-50. doi: 10.1111/jnc.13420. Epub 2015 Nov 24.

15.

Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy.

van Asten JJ, Vettukattil R, Buckle T, Rottenberg S, van Leeuwen F, Bathen TF, Heerschap A.

J Transl Med. 2015 Apr 9;13:114. doi: 10.1186/s12967-015-0458-4.

16.

Preprocessing of raw metabonomic data.

Vettukattil R.

Methods Mol Biol. 2015;1277:123-36. doi: 10.1007/978-1-4939-2377-9_10.

PMID:
25677151
17.

Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma.

Vettukattil R, Hetland TE, Flørenes VA, Kærn J, Davidson B, Bathen TF.

Hum Pathol. 2013 Sep;44(9):1859-66. doi: 10.1016/j.humpath.2013.02.009. Epub 2013 May 6.

PMID:
23656974
18.

2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping.

Esmaeili M, Vettukattil R, Bathen TF.

Transl Oncol. 2013 Apr;6(2):92-8. Epub 2013 Apr 1.

19.

Metabolic profiles of brain metastases.

Sjøbakk TE, Vettukattil R, Gulati M, Gulati S, Lundgren S, Gribbestad IS, Torp SH, Bathen TF.

Int J Mol Sci. 2013 Jan 22;14(1):2104-18. doi: 10.3390/ijms14012104.

20.

Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.

Vettukattil R, Gulati M, Sjøbakk TE, Jakola AS, Kvernmo NA, Torp SH, Bathen TF, Gulati S, Gribbestad IS.

Neurosurgery. 2013 Feb;72(2):186-95; discussion 195. doi: 10.1227/NEU.0b013e31827b9c57.

PMID:
23147779
21.

Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-study.

Bye A, Vettukattil R, Aspenes ST, Giskeødegård GF, Gribbestad IS, Wisløff U, Bathen TF.

PLoS One. 2012;7(7):e42330. doi: 10.1371/journal.pone.0042330. Epub 2012 Jul 30.

22.

In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.

Bathen TF, Heldahl MG, Sitter B, Vettukattil R, Bofin A, Lundgren S, Gribbestad IS.

MAGMA. 2011 Dec;24(6):347-57. doi: 10.1007/s10334-011-0280-9. Epub 2011 Sep 10.

PMID:
21909791

Supplemental Content

Loading ...
Support Center